Glaxo Notes European Commission Authorisation For HIV Drug Dovato
(Alliance News) - GlaxoSmithKline PLC on Wednesday announced the European Commission has given marketing authorisation to HIV-1 drug Dovato.Dovato, a two-drug regimen of dolutegravir and by Read More